Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigida Barberio

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 13, 2024
Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 monthsSonia Facchin, Romilda Cardin, Ilaria Patuzzi, et al.
Therapeutic Advances in Gastroenterology|April 5, 2021
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patientsSonia Facchin, Andrea Buda, Romilda Cardin, et al.
Inflammatory Bowel Diseases|March 5, 2026
Prevalence of disability in inflammatory bowel disease: a systematic review and meta-analysisOlga Maria Nardone, Giulio Calabrese, Alexander C Ford, et al.
Nutrients|June 13, 2025
Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future DirectionsBrigida Barberio, Luisa Bertin, Sonia Facchin, et al.
Gut Microbes|February 7, 2022
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approachBrigida Barberio, Sonia Facchin, Ilaria Patuzzi, et al.
Therapeutic Advances in Gastroenterology|July 12, 2021
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life StudyDavide Massimi, Brigida Barberio, Lorenzo Bertani, et al.
United European Gastroenterology Journal|August 21, 2019
Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea: A prospective, multicenter studyEdoardo Borsotti, Brigida Barberio, Renata D'Incà, et al.
Journal of Clinical Medicine|January 10, 2026
Postoperative Recurrence in Crohn's Disease: Pathophysiology, Risk Stratification, and Management StrategiesLuisa Bertin, Gianluca Semprucci, Camilla Cavagna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2020
Low prevalence of colorectal neoplasia in microscopic colitis: A large prospective multi-center studyEdoardo Borsotti, Brigida Barberio, Renata D'Incà, et al.
Inflammatory Bowel Diseases|September 11, 2019
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With InfliximabBrigida Barberio, Renata D'Incà, Sonia Facchin, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 13, 2024
Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 monthsSonia Facchin, Romilda Cardin, Ilaria Patuzzi, et al.
Therapeutic Advances in Gastroenterology|April 5, 2021
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patientsSonia Facchin, Andrea Buda, Romilda Cardin, et al.
Inflammatory Bowel Diseases|March 5, 2026
Prevalence of disability in inflammatory bowel disease: a systematic review and meta-analysisOlga Maria Nardone, Giulio Calabrese, Alexander C Ford, et al.
Nutrients|June 13, 2025
Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future DirectionsBrigida Barberio, Luisa Bertin, Sonia Facchin, et al.
Gut Microbes|February 7, 2022
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approachBrigida Barberio, Sonia Facchin, Ilaria Patuzzi, et al.
Therapeutic Advances in Gastroenterology|July 12, 2021
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life StudyDavide Massimi, Brigida Barberio, Lorenzo Bertani, et al.
United European Gastroenterology Journal|August 21, 2019
Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea: A prospective, multicenter studyEdoardo Borsotti, Brigida Barberio, Renata D'Incà, et al.
Journal of Clinical Medicine|January 10, 2026
Postoperative Recurrence in Crohn's Disease: Pathophysiology, Risk Stratification, and Management StrategiesLuisa Bertin, Gianluca Semprucci, Camilla Cavagna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2020
Low prevalence of colorectal neoplasia in microscopic colitis: A large prospective multi-center studyEdoardo Borsotti, Brigida Barberio, Renata D'Incà, et al.
Inflammatory Bowel Diseases|September 11, 2019
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With InfliximabBrigida Barberio, Renata D'Incà, Sonia Facchin, et al.
Pageof 14